Investor Relations

HOME > Investor Relations > Consolidated Financial Results

Consolidated Financial Results

(Amounts of less than one million yen are rounded down.)

1. Consolidated Financial Results for the Six Months Ended August 31, 2015 (March 1, 2015, to August 31, 2015)

(1) Consolidated Operating Results

(% indicates changes from the previous corresponding period.)

  Net sales Operating income Ordinary income Net income
Six months ended Million yen % Million yen % Million yen % Million yen %
August 31, 2015 9,248 7.3 199 17.1 193 22.4 224 74.9
August 31, 2014 8,616 50.3 170 - 157 - 128 -

(Note) Comprehensive income:

Six months ended August 31, 2015: ¥248 million [68.5%]
Six months ended August 31, 2014: ¥147 million [-%]


  Net income per share Diluted net income per share
Six months ended Yen Yen
February 28, 2015 11.28
February 28, 2014 6.40

(Note) As the Company has changed the method of financial results presentation effective from the first quarter of the current fiscal year, financial figures and changes from the previous corresponding period for the six months ended August 31, 2014 presented have reflected the change and have been restated. While net sales and operating income have changed due to this restatement, there are no changes for ordinary income and net income.


(2) Consolidated Financial Position

  Total assets Net assets Equity ratio
Million yen Million yen %
Six months ended August 31, 2015 12,531 4,419 35.3
Fiscal year ended February 28, 2015 11,586 4,400 38.0

(Reference) Equity:

Six months ended August 31, 2015: ¥4,419 million
Fiscal year ended February 28, 2015: ¥4,400 million


2. Dividends

  Annual dividends
1st
quarter-end
2nd
quarter-end
3rd
quarter-end
Year-end Total
  Yen Yen Yen Yen Yen
Fiscal year ended February 28, 2015 0.00 4.00 4.00
Fiscal year ending February 29, 2016 0.00      
Fiscal year ending February 29, 2016 (Forecast)     4.00 4.00

(Note) Revision to the dividends forecast announced most recently: None

3. Consolidated Financial Results Forecast for the Fiscal Year Ending February 29, 2016 (March 1, 2015, to February 29, 2016)

  Net sales Operating income Ordinary income Net income Net income per share
  Million yen % Million yen % Million yen % Million yen % Yen
Full year 18,400 0.3 470 3.2 425 (4.8) 300 2.9 14.99

(Note) Revision to the financial results forecast announced most recently: None

Notes:

(1) Changes in significant subsidiaries during the fiscal year under review (changes in specified subsidiaries

resulting in changes in the scope of consolidation): Yes

New inclusion: Two (2);

GSK Co., Ltd
Grand Staff Co., Ltd.

Exclusion: 0

(2) Accounting policies adopted specially for the preparation of quarterly consolidated financial statements: None

(3) Changes in accounting policies, changes in accounting estimates and retrospective restatement

1) Changes in accounting policies due to the revision of accounting standards: None
2) Changes in accounting policies other than 1) above: None
3) Changes in accounting estimates: None
4) Retrospective restatement: None

(4) Total number of issued shares (common shares)

1) Total number of issued shares at the end of the period (including treasury shares):

Fiscal year ended February 28, 2015: 20,010,529 shares
Fiscal year ended February 28, 2015: 20,010,529 shares

2) Total number of treasury shares at the end of the period:

Six months ended August 31, 2015: 519,179 shares
Fiscal year ended February 28, 2015: 79 shares

3) Average number of shares during the period:

Six months ended August 31, 2015: 19,847,177 shares
Six months ended August 31, 2014: 20,010,450 shares

(Note) Concerning the average number of shares during the period, with the introduction of the Board Benefit Trust (“BBT”), the Company’s shares held by Trust & Custody Services Bank, Ltd. (trust account E) are now included in the treasury shares that are deducted from the calculations.

* Presentation regarding the implementation status of the quarterly review procedures

These quarterly financial results are outside the scope of the quarterly review procedures under the Financial Instruments and Exchange Act. At the time of disclosure of these financial results, the review procedures for the quarterly consolidated financial statements under the Financial Instruments and Exchange Act have not been completed.

* Explanation of the proper use of the financial results forecast and other notes

The earnings forecasts and other forward-looking statements herein are based on information currently available to the Company and certain assumptions deemed reasonable as of the date of publication of this document. Actual results may differ significantly from these forecasts due to a wide range of factors. For the conditions as to the assumptions of the earnings forecast, as well as the notice on the use of the earnings forecast, please refer to “Explanation of Consolidated Financial Results Forecast and Other Forward-Looking Statements” on page 3 of the attachment.


Copyright (c) INTERLIFE HOLDINGS CO.,LTD ALL rights reserved